New Alzheimer's AI Tool

Summary by AI BETAClose X

IXICO announced at CTAD 2026 an AI tool that supports radiologists in detecting cerebral microbleeds (CMBs) on MRI, detecting around 90% of microbleeds per participant’s scan and performing consistently across studies and imaging techniques; the two-stage algorithm first locates candidate lesions then classifies true CMBs versus mimics, which could materially reduce radiologist time and inter-reader variability in monitoring vascular safety for anti-amyloid Alzheimer’s trials and thereby increase demand for IXICO’s imaging services and platform.

Disclaimer*

Companies

Ixico (IXI)
UK 100

Latest directors dealings